COVID-19 Vaccine Booster Dose Fails to Enhance Antibody Response to Omicron Variant in Reinfected Healthcare Workers

COVID-19 Vaccine Booster Dose Fails to Enhance Antibody Response to Omicron Variant in Reinfected Healthcare Workers

The emergence of new variants and diverse vaccination regimens have raised uncertainty about vaccine effectiveness against SARS-CoV-2. This study aims to investigate the impact of Omicron primo-/reinfection and primary vaccination schedules on the immunogenicity of an mRNA-based booster dose over a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Leire Fernández-Ciriza, Álvaro González, José Luis del Pozo, Alejandro Fernandez-Montero, Francisco Carmona-Torre, Paula Martínez de Aguirre, María del Mar Sarasa, Silvia Carlos, Gabriel Reina
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Viruses
Subjects:	booster COVID-19 immunogenicity mRNA vaccine Omicron reinfection
Online Access:	https://www.mdpi.com/1999-4915/17/1/78
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
by: Amparo L. Figueroa, et al.
Published: (2025-12-01)

Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
by: Marzia Cavalli, et al.
Published: (2025-01-01)

Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
by: Chao-Chao Qiu, et al.
Published: (2025-02-01)

Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster dosesResearch in context
by: Annalisa Ciabattini, et al.
Published: (2025-03-01)

Effectiveness of Inactivated Coronavirus Disease 2019 Vaccine Against Omicron BA.2.2 Infection in Beijing, China, 2022: A Cohabitation Retrospective Cohort Study
by: Shuaibing Dong, et al.
Published: (2024-12-01)

Influence of backward bifurcation on interpretation of $R_0$ in a model of epidemic tuberculosis with reinfection
by: Benjamin H. Singer, et al.
Published: (2004-02-01)

Assessment of different genotyping markers and algorithms for distinguishing Plasmodium falciparum recrudescence from reinfection in Uganda
by: Alex Mwesigwa, et al.
Published: (2025-02-01)

Sustained immunogenicity of bivalent protein COVID-19 vaccine SCTV01C against antigen matched and mismatched variants
by: Guiqiang Wang, et al.
Published: (2025-12-01)

Assessment of different genotyping markers and algorithms for distinguishing Plasmodium falciparum recrudescence from reinfection in Uganda.
by: Mwesigwa, Alex, et al.
Published: (2025)

Strategic Health Diplomacy: An Indonesia’s Approach in Securing COVID-19 Booster Vaccine Supplies
by: Deasy Silvya Sari, et al.
Published: (2024-06-01)

Does the COVID-19 XBB Omicron subvariant signal the beginning of the end of the pandemic?
by: Jinghao Nicholas Ngiam, et al.
Published: (2024-12-01)

Mushroom β-glucan and polyphenol formulations as natural immunity boosters and balancers: nature of the application
by: Maja Kozarski, et al.
Published: (2023-03-01)

Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave
by: Yeon Ju La, et al.
Published: (2025-02-01)

Clinical spectrum of disease and outcomes in children with Omicron SARS-COV-2 infection in Cape Town, South Africa
by: C. Bekker, et al.
Published: (2024-01-01)

Influence of sleep duration and quality on depression symptoms among nurses during the Omicron outbreak: a cross-sectional survey
by: Yingying Gu, et al.
Published: (2025-02-01)

ATTITUDES TOWARD COVID-19 BOOSTER DOSE VACCINES ACCEPTANCEAMONG HEALTHCARE STUDENTS, KARACHI: A CROSS-SECTIONALANALYSIS
by: Arif Ali, et al.
Published: (2024-12-01)

The immune landscape and viral shedding of Omicron SARS-CoV-2 variants implicate immune escape
by: Weilong Zhang, et al.
Published: (2025-01-01)

Re-presentations to the emergency department initial presentation with COVID-19: Insights from the omicron wave
by: Daniella Audish, et al.
Published: (2025-03-01)

Risk Predictors for Mortality in Inpatients with Cancer and Coronavirus Disease 2019 during the Omicron Wave
by: Kuan-Yu Chen, et al.
Published: (2023-10-01)

Reduced functional independence and multimorbidity increases the risk of severe infection among older patients with Omicron: a multicenter retrospective cohort study
by: Wan Yu, et al.
Published: (2025-02-01)

The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
by: Adewunmi Akingbola, et al.
Published: (2025-12-01)

The trend of phylogenetic and epitope variations of SARS-CoV-2 Omicron sub-lineages in Iran
by: Mehdi Shabani, et al.
Published: (2025-01-01)

Uptake and hesitancy of the second booster dose of COVID-19 vaccine among the general population in China after the surge period of the COVID-19 pandemic: a large-scale national study
by: Xin Liu, et al.
Published: (2025-02-01)

Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster
by: Shun Zhang, et al.
Published: (2025-01-01)

The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
by: Danyi Ao, et al.
Published: (2023-04-01)

REDUCING THE BOOSTER STATIONS ENERGY CONSUMPTION BY WAY OF ELIMINATING OVERPRESSURE IN THE WATER SUPPLY NETWORK
by: G. N. Zdor, et al.
Published: (2015-09-01)

Clinical characteristics and outcomes of children with COVID-19 in pediatric intensive care units during the Omicron wave in Taiwan
by: Jeng-Hung Wu, et al.
Published: (2025-02-01)

Maximizing efficiency and performance of water distribution systems through the implementation of optimization algorithms: A comprehensive analysis of valve and chlorine booster placement and management
by: Mohamadreza Najarzadegan, et al.
Published: (2025-02-01)

A SARS‐CoV‐2 EG.5 mRNA vaccine induces a broad‐spectrum immune response in mice
by: Hongyu Wang, et al.
Published: (2025-01-01)

Booster Vaccination against Yellow Fever in Gambian children-(BoVY) -a Phase 3 clinical trial to establish safety and immunogenicity of repeated YF vaccination in healthy Gambian children of different ages [version 1; peer review: 2 approved]
by: David Jeffries, et al.
Published: (2024-12-01)

Coronil effectively inhibits the interaction of clinically relevant Omicron mutants of SARS-CoV-2 spike proteins with human ACE2 receptor
by: Acharya Balkrishna, et al.
Published: (2025-02-01)

Development of a Recombinant Omicron BA.1 Subunit Vaccine Candidate in Pichia pastoris
by: Sibel Kalyoncu, et al.
Published: (2025-01-01)

Timing of recurrence after treatment of pulmonary TB
by: C.T. Mithunage, et al.
Published: (2024-10-01)

Optimal location selection for digital television signal booster towers in poorly covered areas: application of the EDIS multi-criteria decision-making method
by: Mehdi Soltanifar
Published: (2024-12-01)

Two Years of SARS-CoV-2 Omicron Genomic Evolution in Brazil (2022–2024): Subvariant Tracking and Assessment of Regional Sequencing Efforts
by: Ueric José Borges de Souza, et al.
Published: (2025-01-01)

Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
by: Ching-Wen Hou, et al.
Published: (2025-01-01)

Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
by: Kotou Sangare, et al.
Published: (2025-01-01)

CleanCap M6 inhibits decapping of exogenously delivered IVT mRNA
by: Zachary F. Mandell, et al.
Published: (2025-03-01)

Model for hepatitis C virus transmissions
by: Elamin H. Elbasha
Published: (2013-05-01)

Surveillance Following Hepatitis B Surface Antigen Loss: An Issue Requiring Attention
by: Shuai-Wen Huang, et al.
Published: (2024-12-01)